# RDS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rds

- Industry: Medical Devices & Equipment
- Headquarters: Strasbourg, France
- Website: www.rdsdiag.com
- Total disclosed funding: $30M
- Latest round: Series A (Sep 29, 2025)
- Investors on record: 4

## About

Based in France, Rhythm Diagnostic System SAS specializes in innovative remote patient monitoring solutions, integrating advanced wearable technology with cloud-based platforms to enhance patient care and management.Rhythm Diagnostic System SAS, founded in 2020, is located in Strasbourg, France. The company focuses on developing remote patient monitoring solutions. The CEO, Elie Lobel, leads the organization. In September 2025, RDS SAS raised EUR 14 million in series A funding led by returning investor Bpifrance Investissement Régions, with participation from another returning investor Capital Grand Est. New investors Critical Path Ventures, MACSF, and other unspecified investors also participated in the round. RDS's primary offering is the MultiSense® system, a comprehensive Remote Patient Monitoring solution that integrates a wearable device, the MultiSense® Patch, with a cloud-based platform, the MultiSense® Platform. This innovative system is designed to continuously monitor vital physiological parameters, including heart rate, respiratory rate, oxygen saturation, skin temperature, activity level, and body posture. The MultiSense® Patch is a compact, user-friendly device that captures high-accuracy data, enabling healthcare professionals to transform this information into actionable clinical insights. The solution aims to address critical issues in patient management by facilitating early hospital discharges, reducing healthcare-associated complications, and enhancing overall patient comfort and recovery. MultiSense® has been validated through six clinical investigations and is targeted at healthcare providers in various markets, including Europe and North America, focusing on both hospital and home care environments.RDS generates revenue primarily through the sale of its MultiSense® system, which includes the MultiSense® Patch and subscription access to the MultiSense® Platform. The company engages in business-to-business transactions with healthcare providers, hospitals, and care centers, offering them the necessary tools for remote patient monitoring. The revenue model includes a subscription service for continuous access to the cloud platform, along with potential partnerships with healthcare institutions for the implementation of the MultiSense® system. This structure supports both recurring revenue through subscriptions and one-time sales of the MultiSense® devices. The company plans to utilize the September 2025 funding to speed up its growth in France, Germany, and across the wider European market.

## Funding rounds

- Series A, Sep 29, 2025, $16M — Bpifrance Investissement, Capital Grand Est, MACSF, Critical Path Ventures
- Seed, Oct 10, 2023, $14M — Capital Grand Est

## Investors

- Capital Grand Est (https://capitalatlas.ai/funds/capital-grand-est) — Seed, Series A
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series A
- MACSF — Series A
- Critical Path Ventures (https://capitalatlas.ai/funds/critical-path-ventures) — Series A